Aldeyra Therapeutics, Inc. (ALDX) earnings
ALDX earnings moved a median of +0.72% by the close. Quarterly and annual ALDX reports and results, each read against the price at its own news timestamp. Back to the ALDX overview →
13 measured ALDX earnings events.
Where these ALDX earnings landedvs 13 measured ALDX earnings reactions
| Middle 50% of ALDX earnings reactions | -1.66% to +1.94% |
|---|---|
| Median reaction (to close) | +0.72% |
| Measured reactions | 13 |
Point-in-time · zero look-ahead
Half of the 13 ALDX earnings events with a measured close landed between -1.66% and +1.94%; 54% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Aldeyra Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.64% | -0.64% | |
| Form 10-Q Aldeyra Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +3.53% | +1.76% | |
| Form 10-K Aldeyra Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +3.15% | +4.07% | |
| Form 10-Q Aldeyra Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.91% | -2.43% | |
| Form 10-Q Aldeyra Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +1.45% | +1.94% | |
| Form 10-Q Aldeyra Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -2.33% | -1.37% | |
| Form 10-K/A Aldeyra Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -1.23% | -11.95% | |
| Form 10-K Aldeyra Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +10.50% | +15.65% | |
| Form 10-Q Aldeyra Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -1.21% | +2.79% | |
| Form 10-Q Aldeyra Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -3.44% | +0.72% | |
| Form 10-Q Aldeyra Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +1.18% | -1.66% | |
| Form 10-K Aldeyra Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +1.59% | -4.23% | |
| Form 10-Q Aldeyra Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.79% | +0.90% |
Keep exploring
More ALDX: analyst actions → · SEC filings → · ALDX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| HEMISPHERX BIOPHARMA (HEB) | 779 | -0.06% | 42% |
| TETRAPHASE PHARMACEUTICALS INC (TTPH) | 777 | -0.09% | 47% |
| CYTORI THERAPEUTICS (CYTX) | 774 | -0.72% | 32% |
| Adamis Pharmaceuticals Corporation (ADMP) | 772 | -0.47% | 40% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.